Sustenesis Daily Briefing — 16 November 2026: China, Australia and the United States

China

China's National Healthcare Security Administration released the 2026 national lists for basic medical insurance, maternity insurance and work injury insurance on 14 November, together with the commercial health insurance list for innovative medicines. The basic insurance list adds 107 medicines and removes 34, a net increase of 78 generic names, bringing the total to 3,331: 1,935 Western medicines and 1,396 Chinese patent medicines. The additions include 51 Class 1 innovative medicines across cancer, rare diseases, chronic conditions and mental illness. The agency said this was the first time CAR-T products carrying million-yuan price tags had entered the basic insurance list. Twelve medicines were added to the commercial innovative-drug list, taking it to 28, while two medicines from the previous commercial list moved into basic insurance.

Both lists take effect on 1 January 2027, when the 2025 basic insurance list is repealed. Provincial insurance authorities must update their information systems and medicine databases within the specified timetable. They may not independently alter listed medicines, payment restrictions or Class A and B status, and implementation must be connected to smart supervision systems. The change therefore affects patient reimbursement, prescribing within medical institutions, provincial administration and oversight of insurance funds.

Australia

On 16 November, the National Health and Medical Research Council released clinical advice on the use of puberty suppressants in the care of trans and gender diverse people aged under 18. Public consultation runs from 1 pm that day until 1 pm on 18 January 2027. The advice makes a conditional recommendation for gonadotropin-releasing hormone agonists. They may be considered through a shared decision involving the young person, their parents or carers and clinicians where the young person has commenced puberty, has gender incongruence and has been assessed collaboratively as suitable for treatment. The advice states that this is not a one-size-fits-all decision.

NHMRC says the advice was developed from a systematic review, the GRADE approach and input from a multidisciplinary committee. Because the overall certainty of the available evidence is low, the decision framework calls for comprehensive health assessment, multidisciplinary input tailored to the individual, shared decision-making and regular monitoring. Consultation feedback will feed into the broader national clinical guidelines now being developed, which will also cover hormone treatment and psychosocial support and are expected to enter public consultation in 2028. Federal Health Minister Mark Butler said public gender services for young people are run by the states and territories. ABC reported that existing public-system restrictions in Queensland and the Northern Territory were not automatically displaced by the consultation advice.

United States

The US Administration for Children and Families published a final Head Start rule in the Federal Register on 16 November, removing federal wage and benefit requirements introduced in 2024 but not yet fully implemented. The rescinded provisions would have required programs to develop or update a pay scale for all staff, make education staff wages comparable with those of public preschool teachers, pay all staff enough to cover basic living costs and provide specified benefits. The new rule takes effect on 15 January 2027.

The agency said removing the requirements would allow local grant recipients to decide how to allocate existing funding between workforce compensation and service places, and estimated future annual savings of about US$2.1 billion. The rule does not require programs to reduce current pay or benefits, and local programs may voluntarily retain arrangements contemplated by the 2024 rule; federal, state and local minimum-wage laws continue to apply. The National Head Start Association said removing the federal requirements would not resolve recruitment, retention and classroom-closure pressures, and called for increased congressional funding. The rule changes where responsibility for compensation standards and resource decisions sits; it does not itself reduce Head Start appropriations.

Editorial framework: This briefing uses Sustenesis as an editorial framework for selecting facts, organising relationships and structuring information, with attention to differences and constraints in rules, responsibilities, resources, risks and social relations. Sustenesis functions here as a method of organisation rather than a position or commentary; the body remains limited to verifiable facts.

Sources

National Healthcare Security Administration, “Notice of the National Healthcare Security Administration and the Ministry of Human Resources and Social Security on issuing the National Drug List for Basic Medical Insurance, Maternity Insurance and Work Injury Insurance (2026)”, https://www.nhsa.gov.cn/art/2026/11/14/art_104_23384.html

National Healthcare Security Administration, “NHSA releases the 2026 national medical insurance drug list and commercial health insurance innovative drug list”, https://www.nhsa.gov.cn/art/2026/11/14/art_14_23385.html

Xinhua, “2026 national medical insurance drug list and commercial insurance innovative drug list released”, https://xinhuanet.com/politics/20261114/ee398c5473214b7ebd8a547e70f43e65/c.html

National Health and Medical Research Council, “Advice on the use of puberty suppressants in the care of trans and gender diverse people aged under 18”, https://www.nhmrc.gov.au/health-advice/guidelines-care-trans-and-gender-diverse-people/advice-puberty-suppressants

NHMRC Consultation Hub, “Public consultation – Advice on the use of puberty suppressants in the care of trans and gender diverse people aged under 18”, https://consultations.nhmrc.gov.au/clinical-practice-guidelines/advice-puberty-suppressants/

Australian Government Department of Health, Disability and Ageing, “Statement on NHMRC advice on puberty suppressants”, https://www.health.gov.au/ministers/the-hon-mark-butler-mp/media/statement-on-nhmrc-advice-on-puberty-suppressants?language=en

ABC News, “Puberty blockers should remain an option for trans youth, new national advice finds”, https://www.abc.net.au/news/2026-11-16/puberty-blockers-interim-advice-health-medical-research-council/107376484

Federal Register, “Restoring Flexibility to Support Head Start Program Access”, https://www.govinfo.gov/content/pkg/FR-2026-11-16/pdf/2026-23279.pdf

Associated Press, “Trump administration cancels mandatory pay hike for Head Start teachers”, https://apnews.com/article/5fa1e755af4d46c48f6288132292afda

National Head Start Association, “ACF Releases Final Rule on Head Start Workforce Compensation”, https://nhsa.org/about-nhsa/newsroom/press-releases/acf-releases-final-rule-on-head-start-workforce-compensation/


Discover more from Geoffrey Chen

Subscribe to get the latest posts sent to your email.